|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.450 CAD | +2.30% |
|
+0.56% | -7.68% |
| May. 15 | HLS Therapeutics Inc., Q1 2026 Earnings Call, May 15, 2026 | |
| May. 15 | HLS Therapeutics Q1 Net Loss Narrows on Lower Costs, Higher Revenue | MT |
| Market Cap | 99.38M 86.24M 79.5M 74.49M 139M 9.52B 142M 948M 367M 4.59B 373M 365M 15.95B | P/E Ratio 2026 * |
-15.9x | P/E Ratio 2027 * | -106x |
|---|---|---|---|---|---|
| Enterprise Value | 99.38M 86.24M 79.5M 74.49M 139M 9.52B 142M 948M 367M 4.59B 373M 365M 15.95B | EV / Sales 2026 * |
1.71x | EV / Sales 2027 * | 1.55x |
| Free-Float |
99.48% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: HLS Therapeutics Inc.
| 1 day | +2.30% | ||
| 1 week | +0.56% | ||
| Current month | -3.05% | ||
| 1 month | -4.91% | ||
| 3 months | +4.22% | ||
| 6 months | -10.10% | ||
| Current year | -7.68% |
| 1 week | 4.32 |  | 4.45 |
| 1 month | 4.31 | | 4.69 |
| Current year | 4.22 | | 4.89 |
| 1 year | 4.22 | | 5.76 |
| 3 years | 3 | | 7.12 |
| 5 years | 3 | | 20.52 |
| 10 years | 3 | | 25.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Millian
CEO | Chief Executive Officer | 58 | 2023-04-30 |
John Hanna
DFI | Director of Finance/CFO | 61 | 2024-01-25 |
Ryan Lennox
CMP | Compliance Officer | 45 | 2018-05-06 |
| Director | Title | Age | Since |
|---|---|---|---|
John Welborn
CHM | Chairman | 48 | 2023-06-21 |
John Hanna
BRD | Director/Board Member | 61 | 2023-06-21 |
Craig Millian
BRD | Director/Board Member | 58 | 2023-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Apr. 01 | Option | Director | 3,976 | 0.0127% | ||
| Apr. 01 | Option | Director | 9,343 | 0.0299% | ||
| Apr. 01 | Option | Chairman | 13,120 | 0.0420% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.30% | +0.56% | -9.74% | -24.32% | 99.38M | |
| -0.41% | +3.99% | +9.67% | +99.84% | 94.62B | |
| +2.25% | +9.63% | +44.05% | +154.88% | 51.8B | |
| -1.86% | -9.59% | -18.01% | +214.29% | 21.64B | |
| -0.06% | +0.87% | -12.36% | -30.00% | 8.05B | |
| +1.78% | +4.63% | -32.88% | -26.99% | 7.54B | |
| +1.19% | -1.22% | -11.27% | -36.33% | 6.69B | |
| -1.16% | +3.38% | +12.09% | +23.15% | 6.63B | |
| 0.00% | +0.54% | -1.80% | +17.11% | 5.28B | |
| +0.21% | -4.44% | -12.08% | -18.67% | 3.48B | |
| Average | +0.43% | +0.80% | -3.23% | +37.30% | 20.58B | |
| Weighted average by Cap. | +0.25% | +5.01% | +11.72% | +104.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 58.03M 50.36M 46.42M 43.49M 81.27M 5.56B 82.96M 554M 214M 2.68B 218M 213M 9.31B | 64.31M 55.81M 51.45M 48.2M 90.07M 6.16B 91.94M 614M 238M 2.97B 241M 236M 10.32B |
| Net income | -6.26M -5.44M -5.01M -4.7M -8.77M -600M -8.96M -59.78M -23.14M -289M -23.52M -23.01M -1.01B | -1.05M -911K -840K -787K -1.47M -101M -1.5M -10.02M -3.88M -48.46M -3.94M -3.86M -169M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-11 | 4.450 $ | +2.30% | 27,407 |
| 26-06-10 | 4.350 $ | 0.00% | 5,160 |
| 26-06-09 | 4.350 $ | -1.36% | 210 |
| 26-06-08 | 4.410 $ | -1.34% | 3,010 |
| 26-06-05 | 4.470 $ | +1.02% | 11,211 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HLS Stock
Select your edition
All financial news and data tailored to specific country editions
